Authors at @UMichMedSchool provide a thorough overview of immune stimulatory gene therapy for #glioma, highlighting recent advancements, potential drawbacks, future directions & recommendations for future implementation of clinical trials. 📖 @MolThera
RT @castro2355_mg: Cytotoxic & immune-stimulatory gene therapy using dual-vector Ad-TK and Ad-Flt3L: translational explorations from rodent…
Cytotoxic & immune-stimulatory gene therapy using dual-vector Ad-TK and Ad-Flt3L: translational explorations from rodents to glioma patients - Congratulations to star Post-Doc fellow @faisal_glioma & Pedro Lowenstein for spearheading this effort!
RT @MolTherapy: Adenovirus-mediated combined cytotoxic and immune-stimulatory gene therapy using dual-vector Ad-hCMV-TK and Ad-hCMV-Flt3L:…
RT @MolTherapy: Adenovirus-mediated combined cytotoxic and immune-stimulatory gene therapy using dual-vector Ad-hCMV-TK and Ad-hCMV-Flt3L:…
@alanlparker @ProtEngineer
Adenovirus-mediated combined cytotoxic and immune-stimulatory gene therapy using dual-vector Ad-hCMV-TK and Ad-hCMV-Flt3L: translational explorations from rodents to glioma patients #genetherapy #celltherapy https://t.co/RzL5QASggp